Copyright
©The Author(s) 2025.
World J Nephrol. Jun 25, 2025; 14(2): 99380
Published online Jun 25, 2025. doi: 10.5527/wjn.v14.i2.99380
Published online Jun 25, 2025. doi: 10.5527/wjn.v14.i2.99380
Table 2 Immunohistochemistry of paediatric renal tumors
Renal tumor | Immunohistochemistry expression |
Paediatric cystic nephroma | ER positive[16] |
Metanephric adenoma | WT1 and CD57 positive[24] |
Metanephric stromal tumor | CD34 positive[29,31] |
Metanephric adenofibroma | CD34 positive[33] |
Ossifying renal tumor of infancy | EMA and Vimentin positive [38] |
Nephroblastoma (Wilms tumor) | The blastemal component is WT1 and PAX8 positive; the epithelial component is cytokeratin and Epithelial Membrane Antigen and positive; stromal component is vimentin positive[2] |
Malignant rhabdoid tumor of the kidney | SMARCB1/INI1 loss[64] |
Clear cell sarcoma of the kidney | Cyclin D1 and BCOR positive[73] |
Renal Ewing sarcoma | CD99 and NKX2-2 positive[87-88] |
Renal cell carcinoma with MiT translocations | TFE3 positive[92] |
ALK-rearranged renal cell carcinomas | ALK positive, INI1/SMARCB1 retained[97] |
Eosinophilic solid and cystic renal cell carcinoma | CK20 and PAX8 positive whereas CK7 and C-kit negative[105] |
SMARCB1-deficient renal medullary carcinoma | PAX8, Epithelial Membrane Antigen and vimentin positive [110]; SMARCB1/INI1 loss[111] |
- Citation: Agrawal M, Chowhan AK. Paediatric renal tumors: An insight into molecular characteristics, histomorphology and syndromic association. World J Nephrol 2025; 14(2): 99380
- URL: https://www.wjgnet.com/2220-6124/full/v14/i2/99380.htm
- DOI: https://dx.doi.org/10.5527/wjn.v14.i2.99380